Your browser doesn't support javascript.
loading
Adalimumab with Methotrexate in Treatment-Naïve Japanese Patients with Rheumatoid Arthritis at Risk of Progressive Structural Joint Damage: A Postmarketing Observational Study.
Ito, Yukiko; Hozumi, Kaori; Okada, Yukiko; Kurimoto, Sarina.
Affiliation
  • Ito Y; AbbVie GK, Tokyo, Japan. yukiko.ito@abbvie.com.
  • Hozumi K; AbbVie GK, Tokyo, Japan.
  • Okada Y; AbbVie GK, Tokyo, Japan.
  • Kurimoto S; AbbVie GK, Tokyo, Japan.
Rheumatol Ther ; 4(1): 151-166, 2017 Jun.
Article in En | MEDLINE | ID: mdl-28364381
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Rheumatol Ther Year: 2017 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Rheumatol Ther Year: 2017 Document type: Article Affiliation country: Japan Country of publication: United kingdom